Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1983 1
1984 1
1987 1
1988 1
1989 3
1991 1
1992 2
1993 5
1994 4
1995 7
1996 5
1997 13
1998 12
1999 20
2000 27
2001 33
2002 41
2003 54
2004 62
2005 85
2006 91
2007 116
2008 108
2009 139
2010 176
2011 233
2012 277
2013 301
2014 341
2015 328
2016 306
2017 279
2018 245
2019 234
2020 270
2021 297
2022 281
2023 264
2024 266
2025 252
2026 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,483 results

Results by year

Filters applied: . Clear all
Page 1
Cholangiocarcinoma: Epidemiology and Imaging-Based Review.
Kidanemariam S, Gu J, Yoon JH, Challapalli JV, Fruh V, Sax AJ. Kidanemariam S, et al. Among authors: yoon jh. R I Med J (2013). 2024 May 2;107(5):43-48. R I Med J (2013). 2024. PMID: 38687269 Free article. Review.
Increased CSF drainage by non-invasive manipulation of cervical lymphatics.
Jin H, Yoon JH, Hong SP, Hwang YS, Yang MJ, Choi J, Kang HJ, Baek SE, Jin C, Jung J, Kim HJ, Seo J, Won J, Lim KS, Jeon CY, Lee Y, Davis MJ, Park HS, McDonald DM, Koh GY. Jin H, et al. Among authors: yoon jh. Nature. 2025 Jul;643(8072):755-767. doi: 10.1038/s41586-025-09052-5. Epub 2025 Jun 4. Nature. 2025. PMID: 40468071 Free PMC article.
Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study.
Sangro B, Kudo M, Erinjeri JP, Qin S, Ren Z, Chan SL, Arai Y, Heo J, Mai A, Escobar J, Lopez Chuken YA, Yoon JH, Tak WY, Breder VV, Suttichaimongkol T, Bouattour M, Lin SM, Peron JM, Nguyen QT, Yan L, Chiu CF, Santos FA, Veluvolu A, Thungappa SC, Matos M, Żotkiewicz M, Udoye SI, Kurland JF, Cohen GJ, Lencioni R; EMERALD-1 Investigators. Sangro B, et al. Among authors: yoon jh. Lancet. 2025 Jan 18;405(10474):216-232. doi: 10.1016/S0140-6736(24)02551-0. Epub 2025 Jan 8. Lancet. 2025. PMID: 39798579 Free PMC article. Clinical Trial.
GULP1 as a novel diagnostic and predictive biomarker in hepatocellular carcinoma.
Kim HS, Yoon JH, Choi JY, Yoon MG, Baek GO, Kang M, Jang SH, Park W, Go Y, Ng JT, Nam SW, Jeong JY, Han JE, Cho HJ, Lim SB, Kim SS, Cheong JY, Eun JW. Kim HS, et al. Among authors: yoon jh. Clin Mol Hepatol. 2025 Jul;31(3):914-934. doi: 10.3350/cmh.2024.1038. Epub 2025 Feb 6. Clin Mol Hepatol. 2025. PMID: 39914372 Free PMC article.
4,483 results